Cumberland Pharmaceuticals Pitch Deck

12 VIBATIVⓇ [telavancin) for injection Injectable antibiotic that treat serious, life-threatening infections Hospital product that aligns well with our current infrastructure Strong potential to continue brand growth Patent protection through 2027 Established network of worldwide licensing partners New study data demonstrates superiority over vancomycin in select patients with bacterial pneumonia. Published in Infectious Disease and Therapy NDC 0469-3575-50 Vibativ telavancin for injection 750 mg/vial For Intravenous Infusion Only For Dosage, Reconstitution, and D See Package Insert Medication Guide ATTENTION: Dispense with enclosed Rx Only 357550 12

View entire presentation